Program for stress reduction and lifestyle changes in IBS patients
Effect of a Stress Reduction and Lifestyle Modification Programme on the Quality of Life of Irritable Bowel Syndrome Patients (MBM IBS)
This study is testing whether a 10-week program that combines stress reduction and lifestyle changes can help people with irritable bowel syndrome feel better and improve their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 118 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Universität Duisburg-Essen Academic / other |
| Locations | 1 site (Bamberg, Bavaria) |
| Trial ID | NCT06145022 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effectiveness of a 10-week multimodal stress reduction and lifestyle modification program for patients with irritable bowel syndrome (IBS). The program includes group sessions focused on stress management, physical activity, dietary changes, and self-help strategies. Participants will be divided into an intervention group receiving the program and a waitlist control group that will receive educational materials. The study aims to assess the program's impact on IBS symptom severity, quality of life, and mental well-being using validated measurement scales.
Who should consider this trial
Good fit: Ideal candidates are adults diagnosed with irritable bowel syndrome who have a symptom severity score above 75.
Not a fit: Patients with severe mental illness, significant comorbid conditions, or those currently pregnant may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve the quality of life and symptom management for patients with irritable bowel syndrome.
How similar studies have performed: Previous pilot studies have shown success with similar integrative approaches for chronic inflammatory bowel diseases, suggesting potential efficacy for IBS as well.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * confirmed diagnosis of irritable bowel syndrome (IBS with diarrhea, IBS with constipation, mixed-type IBS, or unspecified IBS); IBS-SSS Score \> 75 Exclusion Criteria: * Severe mental illness (e.g., clinically significant depression, substance use disorder, schizophrenia) * Severe comorbid somatic illness (e.g., oncological disease) * Pregnancy * Participation in other stress reduction programs or clinical studies on psychological interventions * Known intolerances (fructose, lactose), celiac disease, etc.
Where this trial is running
Bamberg, Bavaria
- Sozialstiftung Bamberg — Bamberg, Bavaria, Germany (Recruiting)
Study contacts
- Principal investigator: Jost Langhorst, Prof. Dr. — University of Duisburg-Essen/Sozialstiftung Bamberg
- Study coordinator: Sandra Utz, PhD
- Email: sandra.utz@sozialstiftung-bamberg.de
- Phone: +49 951 503
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.